Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2023 ∙ Watanabe, A. Iwagami, M. Yasuhara, J. Takagi, H. Kuno, T.

Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Bobrovitz, N. Ware, H. Ma, X. Li, Z. Hosseini, R. Cao, C. Selemon, A. Whelan, M. Premji, Z. Issa, H. Cheng, B. Abu Raddad, L. J. Buckeridge, D. L. Van Kerkhove, M. D. Piechotta, V. Higdon, M. M. Wilder-Smith, A. Bergeri, I. Feikin, D. R. Arora, R. K. Patel, M. K. Subissi, L.

Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Wu, Chi-Fang Highfield, Linda Swint, John M. Lairson, David R.

Provider-Based HPV Vaccine Promotion Interventions: A Meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Dinga, J. N. Kabakama, S. Njimoh, D. L. Chia, J. E. Morhason-Bello, I. Lumu, I.

Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Xu, S. Li, J. Wang, H. Wang, F. Yin, Z. Wang, Z.

Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2023 ∙ Beran, A. Mhanna, A. Mhanna, M. Hassouneh, R. Abuhelwa, Z. Mohamed, M. F. H. Sayeh, W. Musallam, R. Assaly, R. Abdeljawad, K.

Real-world effectiveness of COVID-19 vaccination in liver cirrhosis: a systematic review with meta-analysis of 51,834 patients

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Xu, M. Liu, C. Du, Z. Bai, Y. Wang, Z. Gao, C.

Real-world effectiveness of monkeypox vaccines: A systematic review

  • Adults
  • Mpox
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Palalay, H. Vyas, R. Tafuto, B.

Real-world effectiveness of mRNA COVID-19 vaccines in the elderly during the Delta and Omicron variants: Systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Sarwar, M. U. Waasia, F. Z. Aloqbi, A. A. Alandiyjany, M. Alqahtani, R. M. Hafiz, L. A. Shamlan, G. Albreiki, M.

Real-world effectiveness of the inactivated COVID-19 vaccines against variant of concerns: meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Xu, W. Ren, W. Wu, T. Wang, Q. Luo, M. Yi, Y. Li, J.

Real-World Safety of COVID-19 mRNA Vaccines: A Systematic Review and Meta-Analysis

  • All age groups
  • Healthcare workers
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...